10X Genomics Inc operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares 10X Genomics Inc with three other
companies in this sector in UNITED STATES :
Denali Therapeutics Inc
sales of $335.66 million
of which 100%
was Biological Products),
of which 48%
was Product revenue - Filtration products), and
Halozyme Therapeutics, Inc.
of which 33%